AIM
INSP icon

Arcadia Investment Management’s Inspire Medical Systems INSP Stock Holding History

Arcadia Investment Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-141
Closed -$30.3K – 319
2024
Q1 		$30.3K Hold
141
– – 0.01% 226
2023
Q4 		$28.7K Sell
141
-83
-37% -$13.4K 0.01% 236
2023
Q3 		$44.5K Buy
224
+69
+45% +$17.4K 0.01% 219
2023
Q2 		$50.3K Sell
155
-204
-57% -$58.3K 0.01% 219
2023
Q1 		$84K Buy
359
+173
+93% +$43.7K 0.02% 188
2022
Q4 		$46.9K Buy
+186
New +$39.7K 0.01% 229
2019
Q2 		– Sell
-2,856
Closed -$162K – 318
2019
Q1 		$162K Buy
2,856
+1,904
+200% +$103K 0.05% 124
2018
Q4 		$40K Buy
+952
New +$40.5K 0.01% 200

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Arcadia Investment Management's INSP Position: Q2 2024 in Review

Arcadia Investment Management sold out of Inspire Medical Systems (INSP) in Q2 2024, closing a stake of 141 shares — an estimated $30.3K sold.

Arcadia Investment Management first reported a position in INSP in Q4 2018 and held it in 8 quarters. The position peaked at $162K in Q1 2019. 325 funds tracked by Wall St. Rank hold INSP as of Q2 2024.

  • Arcadia Investment Management reported no remaining Inspire Medical Systems position as of Q2 2024 after selling out during the quarter.
  • Arcadia Investment Management sold 141 Inspire Medical Systems shares in Q2 2024, an estimated $30.3K.
  • Arcadia Investment Management first reported a position in Inspire Medical Systems in Q4 2018 and held it in 8 quarters.
  • Arcadia Investment Management's Inspire Medical Systems position peaked at $162K in Q1 2019.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2024.

Based on Arcadia Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.